Search results
The true tragedy of the Covid-19 vaccines
The Telegraph via Yahoo News· 3 days agoVaccination is one of mankind’s most miraculous innovations. The eradication of smallpox, and the retreat of measles and other cruel afflictions, mean...
Cancer vaccines are having a renaissance
Technology Review· 2 days agoPersonalized cancer vaccines like the ones Moderna and BioNTech are developing are tailored to each patient’s particular cancer. Together these neoantigens form a kind of ...
Pfizer Jumps On 'Massive' First-Quarter Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 3 days agoExcluding that, Paxlovid sales still topped expectations. Comirnaty, the Covid vaccine Pfizer...
Pfizer Stock Jumps On 'Massive' Upside Thanks To Paxlovid Surprise
Investor's Business Daily· 3 days agoComirnaty, the Covid vaccine Pfizer developed with BioNTech (BNTX) brought in $354 million in sales,...
Safe and Effective? The New York Times Revisits the COVID Jab. - The American Spectator | USA News...
American Spectator· 21 hours agoIt has taken three years, but the New York Times has finally admitted that maybe, just maybe, there are some serious side effects to COVID vaccines. AstraZeneca, which has been fighting a class-action ...
Pfizer lifts profit view on cost cuts, demand for COVID products
Reuters· 3 days ago, opens new tab lifted its annual earnings forecast on Wednesday and reported a first-quarter profit...
TIME100 Health: Katalin Kariko and Drew Weissman
Time via Yahoo News· 2 days agoIn under a year, both Pfizer-BioNTech and Moderna developed mRNA-based COVID-19 vaccines based on Kariko and Weissman’s method. The shots helped to slow...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 2 days agoShares of Moderna rose more than 7 percent in early morning trading. Pfizer, the New York-based drug...
The images that show the two sides of AstraZeneca’s vaccine ‘miracle’
The Telegraph via Yahoo Finance· 4 days agoJamie Scott is nothing if not a fighter. He must be to have survived a reaction to his Covid-19...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 3 days agoSales also tumbled 20% to $14.88 billion, but topped forecasts for $13.87 billion. As expected,...